As of May 26
| -0.06 / -3.12%|
The 5 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 3.00, with a high estimate of 3.25 and a low estimate of 1.50. The median estimate represents a +61.29% increase from the last price of 1.86.
The current consensus among 5 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.